Drug Profile
BAY 383045
Alternative Names: PDE 1/5 inhibitor - Bayer; PDE I/V inhibitor - Bayer; Phosphodiesterase I/V inhibitor - BayerLatest Information Update: 09 Jul 2002
Price :
$50
*
At a glance
- Originator Bayer
- Class
- Mechanism of Action Type 1 cyclic nucleotide phosphodiesterase inhibitors; Type 5 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Angina pectoris; Myocardial infarction
Most Recent Events
- 10 May 1999 New profile
- 10 May 1999 Preclinical development for Angina pectoris in Germany (Unknown route)
- 10 May 1999 Preclinical development for Myocardial infarction in Germany (Unknown route)